Andy Smith talks on anti-infectives from St. Marys Hospital,
London, the origin of penicillin and modern day anti-infectives. He
takes a brief look at history to uncover future risks and reviews
the issues that investors need to be aware of, such as, resistance,
toxicity and the problems of developing new anti-infectives for
hospital use. Andy explores the issues for new anti-infectives and
the argument around the non-inferiority margin of new agents.
Join the discussion, share your views